Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase Expression-Reference-Cited by-同舟云学术

Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase Expression

Published:2021-11 Issue:11 Volume:141 Page:2730-2740.e9
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Cao Yonghao^ORCID,Harvey Bohdan P.^ORCID,Hong Feng^ORCID,Ruzek Melanie^ORCID,Wang Jing^ORCID,Murphy Erin R.^ORCID,Kaymakcalan Zehra^ORCID

Funder

AbbVie Inc

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference56 articles.

1. Treatment of hidradenitis suppurativa with etanercept injection;Adams;Arch Dermatol,2010

2. Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing;Ashcroft;Wound Repair Regen,2012

3. TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an Fc-dependent mechanism;Bloemendaal;J Crohns Colitis,2018

4. Metalloproteinases and wound healing;Caley;Adv Wound Care (New Rochelle),2015

5. Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis;Cao;Sci Transl Med,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab inhibits TNF-α-dependent activation of the NLRP3/IL-1β pathway in acne inversa;Heliyon;2024-06

2. Therapeutic TNF Inhibitors Exhibit Differential Levels of Efficacy in Accelerating Cutaneous Wound Healing;JID Innovations;2024-01

3. Recent advances in strategies to target the behavior of macrophages in wound healing;Biomedicine & Pharmacotherapy;2023-09

4. Editorial: Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease;Frontiers in Molecular Biosciences;2023-03-10

5. HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa;Pharmaceutics;2023-02-12